Riskpilot← Back to searchSign inGet full accessBionor AB
ABActiveOrg 5565849212Heljesvägen 9Sewerage · NACE 3700Est. 20001-4 employees
Revenue 2024
SEK 4,7M
+4% vs 2023
EBITDA margin
5.8%
-5% vs 2023
Equity ratio
81.7%
Financial strength
Net profit 2024
SEK 212K
-17% vs 2023
| Revenue | SEK 4,7M | +4% |
| EBITDA | SEK 276K | -5% |
| Net profit | SEK 212K | -17% |
| Total assets | SEK 1,4M | +16% |
| Equity | SEK 1,2M | +22% |
| Employees | — | — |
Legal name
Bionor AB
Org number
5565849212
Legal form
Aktiebolag
NACE code
3700 · Sewerage
Founded
8 februari 2000
Share capital
SEK 100 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten externa firmatecknaren
Company purpose
Bolaget skall bedriva service, montering och försäljning av avloppsreningsanläggningar, reparationer av bilar, verkstadsmaskiner och traktorer och därmed förenlig verksamhet.
Address
Heljesvägen 9
Email
kontor@bionor.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 593 | 3 661 | 3 490 | 4 548 | 4 732 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 212 | 234 | −127 | 291 | 276 |
| Depreciation & amort. | −4 | −3 | −0 | −0 | −2 |
| EBIT | 208 | 231 | −127 | 291 | 274 |
| Net financials | −5 | 6 | −3 | −2 | −1 |
| Profit before tax | 203 | 236 | −129 | 289 | 273 |
| Tax | −18 | −49 | −0 | −35 | −61 |
| Net profit | 185 | 187 | −129 | 254 | 212 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 132 | 1 187 | 1 290 | 1 224 | 1 423 |
| Equity | 639 | 826 | 697 | 951 | 1 163 |
| Long-term debt | 141 | 0 | 131 | 0 | 0 |
| Short-term debt | 351 | 361 | 462 | 272 | 260 |
| Total debt | 492 | 361 | 593 | 272 | 260 |
EBITDA margin
5.8%
This company
15.8%
Market median
-63% vs market
20202024
Equity ratio
81.7%
This company
38.2%
Market median
+114% vs market
20202024
Return on equity
18.2%
This company
18.4%
Market median
+1% vs market
20202024
Net profit margin
4.5%
This company
8.1%
Market median
-44% vs market
20202024
Asset turnover
3.33×
This company
1.12×
Market median
+197% vs market
20202024
Debt / equity
0.22×
This company
0.62×
Market median
+65% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JM External Signatory | External Signatory | 2022 |
| Former (1) | ||
UK Authorized Recipient of Service | Authorized Recipient of Service | 2022 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2026 | |
| Deputy Board Member | 2025 | |
| Former (2) | ||
| Deputy Board Member | 2022 – 2025 | |
| Board of Directors | 2025 – 2026 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Bionor AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ulf Kalborg | Authorized Recipient of Service | 0 companies |
| Johan Michael Pettersen | External Signatory | 0 companies |
| Michal Zbigniew Dyk | Board of Directors | 0 companies |
| Honorata Cecylia Dyk | Deputy Board Member | 0 companies |
| Zbigniew Jerzy Dyk | Deputy Board Member | 0 companies |
| Michal Zbigniew Dyk | Board of Directors | 0 companies |